July 2, 2020
The first COVID-19 vaccine to be developed in the southern hemisphere has progressed to human trials.
But the company behind it is funded by the United States’ National Institute of Allergy and Infectious Diseases, so will it stay in Australia?
Podcast:
- Click to share on Facebook (Opens in new window)
- Click to share on Twitter (Opens in new window)
- Click to share on Telegram (Opens in new window)
- Click to share on LinkedIn (Opens in new window)
- Click to share on Reddit (Opens in new window)
- Click to share on WhatsApp (Opens in new window)
- Click to share on Tumblr (Opens in new window)
- Click to share on Pinterest (Opens in new window)
- Click to share on Pocket (Opens in new window)
- Click to email a link to a friend (Opens in new window)
- Click to print (Opens in new window)
